🇺🇸 FDA
Pipeline program

Active Comparator CT1812

COG2201

Phase 2 small_molecule terminated

Quick answer

Active Comparator CT1812 for Age-Related Macular Degeneration is a Phase 2 program (small_molecule) at COGNITION THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
COGNITION THERAPEUTICS INC
Indication
Age-Related Macular Degeneration
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials